208 related articles for article (PubMed ID: 2430547)
1. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
[TBL] [Abstract][Full Text] [Related]
2. Distribution of five antigens in hepatocellular carcinoma.
Thung SN; Gerber MA; Sarno E; Popper H
Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
[TBL] [Abstract][Full Text] [Related]
3. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
Espinoza CG; Pillarisetti SG; Azar HA
Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
Ruck P; Xiao JC; Kaiserling E
Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
Pollice L; Ricco R; Russo S; Maiorano E; Pagniello G; Delfino-Pesce V
Appl Pathol; 1988; 6(2):73-81. PubMed ID: 2455530
[TBL] [Abstract][Full Text] [Related]
8. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity.
Than KW; Okayasu I; Akashi T
Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960
[TBL] [Abstract][Full Text] [Related]
9. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies.
Guindi M; Yazdi HM; Gilliatt MA
Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
Ferrandez-Izquierdo A; Llombart-Bosch A
Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
[TBL] [Abstract][Full Text] [Related]
11. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of hepatocellular nodular lesions.
Hytiroglou P; Theise ND
Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
[TBL] [Abstract][Full Text] [Related]
14. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
[TBL] [Abstract][Full Text] [Related]
15. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
16. Alpha fetoprotein and carcinoembryonic antigen producing hepatocellular carcinoma. A case report studied by immunohistochemistry.
Amano S; Kataoka H; Hazama F; Nakatake M; Maki A
Acta Pathol Jpn; 1985 Jul; 35(4):969-74. PubMed ID: 2416187
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical evaluation of liver fine-needle aspirations.
Bedrossian CW; Davila RM; Merenda G
Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
[TBL] [Abstract][Full Text] [Related]
18. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Swanson BJ; Yearsley MM; Marsh W; Frankel WL
Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
